Enforcement record
Administrative Guidance disclosure naming 日本政府（厚生労働省）
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Administrative Guidance
Law
Specified Commercial Transactions Act
Authority
Ministry of Health, Labour and Welfare
Action date
18 July 2018
RegBase evidence report
Japanese public-record enforcement check
Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.
- Report ID
- RB-EN-ENFORCEMENT-TOKUSHOHO-RI-BEN--202608182209
- Generated at
- 19 August 2026 at 07:09
- Record URL
- https://regbase.jp/en/enforcement/tokushoho-ri-ben-zheng-fuhou-sheng-lao-dong-sheng-20180718
1. Review Summary
| Disclosure name | 日本政府（厚生労働省） | Corporate Number | Not stated in the disclosure |
|---|---|---|---|
| Enforcement record | 1 record | Other confirmed records for this company | Outside this report's scope |
| Action date | 18 July 2018 | Authority | Ministry of Health, Labour and Welfare |
| Law | Specified Commercial Transactions Act | Action type | Administrative Guidance |
| Source status | Preserved public-source archive recorded | ||
This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.
2. Published Information
| Published name | 日本政府（厚生労働省） |
|---|
3. Enforcement Record
| Target name in disclosure | 日本政府（厚生労働省） |
|---|---|
| Authority | Ministry of Health, Labour and Welfare (厚生労働省) |
| Law / action type | Specified Commercial Transactions Act / Administrative Guidance |
| Action / announcement date | Action: 18 July 2018 / Announcement: 25 April 2026 |
| English summary | With this signing exchange, the scope of pharmaceuticals subject to GMP mutual recognition under the agreement has been expanded to include active pharmaceutical ingredients (APIs), sterile pharmaceuticals, vaccines, and other biological medicines, covering most pharmaceuticals. |
| Original Japanese text | この署名交換をもって、協定によるＧＭＰ相互承認の対象医薬品が、原薬（有効成分）、無菌医薬品、ワクチンなどの生物学的医薬品にも拡大し、ほとんどの医薬品をカバーすることになりました。 |
| Official source | https://www.mhlw.go.jp/stf/newpage_00364.html |
| Source archive | https://kiroku.today/a/ec9f393b0aggo0mk |
| Extraction / evidence timestamps | Extracted: 25 April 2026 at 21:01 / Evidence checked: 25 April 2026 at 21:01 / Archive captured: 27 April 2026 at 09:33 |
4. Business Location and Permit Details
No additional structured business-location or permit fields are recorded for this disclosure.
5. Other Confirmed Records for This Company
This report covers the single government disclosure shown on this page.
Reviewer Notes
| Reviewer | Team / company | ||
|---|---|---|---|
| Review purpose | |||
| Additional notes | |||
- □ Official source URL or archived source was checked.
- □ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
- □ This document is understood as a public-record evidence file, not a credit decision or legal opinion.
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Free report
Save the disclosure record naming 日本政府（厚生労働省）
Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.
Preserved evidence by Kiroku
Review the preserved source for 日本政府（厚生労働省）
Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.
For developers: JSON integration details
You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.
Action summary
- Company
- 日本政府（厚生労働省）Japanese onlyOriginal: 日本政府（厚生労働省）
- Governing law
- Specified Commercial Transactions Act特定商取引法
- Action type
- Administrative Guidance行政指導
- Action date
- 18 July 2018
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品
Violation
With this signing exchange, the scope of pharmaceuticals subject to GMP mutual recognition under the agreement has been expanded to include active pharmaceutical ingredients (APIs), sterile pharmaceuticals, vaccines, and other biological medicines, covering most pharmaceuticals.
Show original Japanese text
この署名交換をもって、協定によるＧＭＰ相互承認の対象医薬品が、原薬（有効成分）、無菌医薬品、ワクチンなどの生物学的医薬品にも拡大し、ほとんどの医薬品をカバーすることになりました。
Compliance context
Low-mediumAdministrative guidance or supervision was publicly disclosed by the authority.
Consumer transaction law covering specified sales channels such as mail order, door-to-door sales, telemarketing, and related practices.
Use as a monitoring signal. Confirm details before treating it as a formal sanction.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-25T12:01:32.309+00:00
- Evidence checked
- 2026-04-25T12:01:32.309+00:00
- Archive captured
- 2026-04-27T00:33:27.198371+00:00
Show audit JSON
{
"record": {
"id": "08040221-4aec-438e-b81c-0777c0496b2b",
"url": "https://regbase.jp/en/enforcement/tokushoho-ri-ben-zheng-fuhou-sheng-lao-dong-sheng-20180718",
"company_name_original": "日本政府（厚生労働省）",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "特定商取引法",
"en": "Specified Commercial Transactions Act"
},
"action_type": {
"ja": "行政指導",
"en": "Administrative Guidance"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 60,
"method": "extracted_japanese_name",
"method_label": "Company name extracted from the Japanese public disclosure",
"notes": "The linked company profile has not been verified under the current identity policy."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Low-medium",
"actionMeaning": "Administrative guidance or supervision was publicly disclosed by the authority.",
"practicalNote": "Use as a monitoring signal. Confirm details before treating it as a formal sanction.",
"lawContext": "Consumer transaction law covering specified sales channels such as mail order, door-to-door sales, telemarketing, and related practices."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/tokushoho-ri-ben-zheng-fuhou-sheng-lao-dong-sheng-20180718",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_00364.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/ec9f393b0aggo0mk",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_00364.html",
"archiveCapturedAt": "2026-04-27T00:33:27.198371+00:00",
"extractedAt": "2026-04-25T12:01:32.309+00:00",
"translatedAt": "2026-05-01T09:39:49.572+00:00",
"evidenceCheckedAt": "2026-04-25T12:01:32.309+00:00",
"generatedAt": "2026-08-18T22:09:30.760Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.